Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**7-aminocephalosporanic acid (7-ACA)** is a natural beta-lactam compound and the core chemical structure used as a synthon for the synthesis of cephalosporin antibiotics. It serves as the essential nucleus for producing a wide range of semisynthetic cephalosporins by chemical modification at specific positions on its bicyclic structure. Cephalosporins derived from 7-ACA are broad-spectrum antibiotics effective against various Gram-positive and Gram-negative bacteria due to their ability to inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking[1][8]. The compound itself is not used therapeutically but is an industrial intermediate in pharmaceutical manufacturing[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 7-aminocephalosporanic acid.